Semmelweis Publications
  • Main page

    • Prohászka, Zoltán Semmelweis University affiliated publications (2020-2025)

    Year:
    Order by:
    Authorship:
    Number of publications: 73
    1.
    Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
    Sinkovits, G;Mezo, B;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.663187 (Copy DOI)
    2.
    Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
    Kiszel, P;Sík, P;Miklós, J;Kajdácsi, E;Sinkovits, G;Cervenak, L;Prohászka, Z
    D1
    SCIENTIFIC REPORTS
    2023.
    DOI:10.1038/s41598-023-40103-x (Copy DOI)
    3.
    Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
    Roose, E;Tellier, AS;Tellier, E;Sinkovits, G;Joly, BS;Dekimpe, C;Kaplanski, G;Le Besnerais, M;Mancini, I;Falter, T;Von Auer, C;Feys, HB;Reti, M;Rossmann, H;Vandenbulcke, A;Pareyn, I;Voorberg, J;Greinacher, A;Benhamou, Y;Deckmyn, H;Fijnheer, R;Prohaszka, Z;Peyvandi, F;Lämmle, B;Coppo, P;De Meyer, SF;Veyradier, A;Vanhoorelbeke, K
    D1
    BLOOD
    2020.
    DOI:10.1182/blood.2019004221 (Copy DOI)
    4.
    Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura
    Tarasco, E;Bütikofer, L;Friedman, KD;George, JN;Hrachovinova, I;Knöbl, PN;Matsumoto, M;von Krogh, AS;Aebi-Huber, I;Cermakova, Z;Górska-Kosicka, M;Jalowiec, KA;Largiadèr, CR;Prohászka, Z;Sinkovits, G;Windyga, J;Lämmle, B;Hovinga, JAK
    D1
    BLOOD
    2021.
    DOI:10.1182/blood.2020009801 (Copy DOI)
    5.
    Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
    Matosevic, M;Kos, I;Davidovic, M;Ban, MJ;Matkovic, H;Jakopcic, I;Brinar, IV;Szilagyi, A;Csuka, D;Sinkovits, G;Prohaszka, Z;Vrljicak, K;Lamot, L
    Q2
    FRONTIERS IN PEDIATRICS
    2023.
    DOI:10.3389/fped.2023.1092860 (Copy DOI)
    6.
    Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
    Hurler, L;Szilágyi, A;Mescia, F;Bergamaschi, L;Mezo, B;Sinkovits, G;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Csuka, D;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Vályi-Nagy, I;Wüerzner, R;Lyons, PA;Toonen, EJM;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1162171 (Copy DOI)
    7.
    Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura
    De Waele, L;Sakai, K;Mancini, I;Sinkovits, G;Falter, T;Inoue, T;Agosti, P;Rossmann, H;Von Auer, C;Tersteeg, C;Meyer, SFD;Joly, BS;Veyradier, A;Coppo, P;Fijnheer, R;Peyvandi, F;Prohászka, Z;Laemmle, B;Vanhoorelbeke, K
    D1
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS
    2024.
    DOI:10.1016/j.jtha.2023.10.014 (Copy DOI)
    8.
    Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
    Nádasdi, A;Sinkovits, G;Bobek, I;Lakatos, B;Förhécz, Z;Prohászka, ZZ;Réti, M;Arató, M;Cseh, G;Masszi, T;Merkely, B;Ferdinandy, P;Vályi-Nagy, I;Prohászka, Z;Firneisz, G
    Q3
    BIOMARKERS IN MEDICINE
    2022.
    DOI:10.2217/bmm-2021-0717 (Copy DOI)
    9.
    Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
    Aigner, C.; Gaggl, M.; Schmidt, S.; Kain, R.; Kozakowski, N.; Oszwald, A.; Prohászka, Z.; Sunder-Plassmann, R.; Schmidt, A.; Sunder-Plassmann, G.;
    Q1
    KIDNEY INTERNATIONAL REPORTS 2468-0249 2468-0249
    2023.
    DOI:10.1016/j.ekir.2023.05.010 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    10.
    Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
    Sinkovits, G;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhecz, Z;Mezo, B;Csuka, D;Hurler, L;Kajdácsi, E;Cervenak, L;Kiszel, P;Masszi, T;Vályi-Nagy, I;Prohászka, Z
    Q1
    THROMBOSIS AND HAEMOSTASIS
    2022.
    DOI:10.1055/s-0041-1740182 (Copy DOI)
    11.
    Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy-a multicentre retrospective PDWP and IEWP EBMT study
    Svec, P;Elfeky, R;Galimard, JE;Higham, CS;Dalissier, A;Quigg, TC;Sanchez, DB;Lum, SH;Faraci, M;Cole, T;Pichler, H;Benítez-Carabante, MI;Horakova, J;Vicent, MG;Yanir, A;Fagioli, F;Wölfl, M;von der Weid, N;Protheroe, R;Krivan, G;Speckmann, C;James, B;Avcin, SL;Bertrand, Y;Verna, M;Riha, P;Patrick, K;Cesaro, S;Kalwak, K;Bierings, M;Büchner, J;Mellgren, K;Prohászka, Z;Neven, B;Lankester, A;Corbacioglu, S
    Q1
    BONE MARROW TRANSPLANTATION
    2023.
    DOI:10.1038/s41409-022-01852-x (Copy DOI)
    12.
    COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant
    Pinte, L;Sorohan, BM;Prohászka, Z;Gherghiceanu, M;Baicus, C
    Q3
    ROMANIAN JOURNAL OF INTERNAL MEDICINE
    2022.
    DOI:10.2478/rjim-2021-0040 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    13.
    Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
    Rysava, R;Peiskerova, M;Tesar, V;Benes, J;Kment, M;Szilágyi, A;Csuka, D;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.1001366 (Copy DOI)
    14.
    Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
    Hurler, L;Toonen, EJM;Kajdácsi, E;van Bree, B;Brandwijk, RJMGE;de Bruin, W;Lyons, PA;Bergamaschi, L;Sinkovits, G;Cervenak, L;Würzner, R;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.1039765 (Copy DOI)
    15.
    Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation
    Papp, A;Papp, K;Uzonyi, B;Cserhalmi, M;Csincsi, AI;Szabó, Z;Bánlaki, Z;Ermert, D;Prohászka, Z;Erdei, A;Ferreira, VP;Blom, AM;Józsi, M
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.845953 (Copy DOI)
    16.
    Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor
    Andersson, LI;Sjöeströem, DJ;Quach, HQ;Häegerströem, K;Hurler, L;Kajdácsi, E;Cervenak, L;Prohászka, Z;Toonen, EJM;Mohlin, C;Mollnes, TE;Sandgren, P;Tjernberg, I;Nilsson, PH
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms25021091 (Copy DOI)
    17.
    Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
    Henry, BM;Sinkovits, G;Szergyuk, I;de Oliveira, MHS;Lippi, G;Benoit, JL;Favaloro, EJ;Pode-Shakked, N;Benoit, SW;Cooper, DS;Muller, V;Ivanyi, Z;Gal, J;Reti, M;Gopcsa, L;Remenyi, P;Szathmary, B;Lakatos, B;Szlavik, J;Bobek, I;Prohaszka, ZZ;Forhecz, Z;Csuka, D;Hurler, L;Kajdacsi, E;Cervenak, L;Mezo, B;Kiszel, P;Masszi, T;Valyi-Nagy, I;Prohaszka, Z
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.796109 (Copy DOI)
    18.
    Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors
    Szabó, Z;Szabó, T;Bodó, K;Kemenesi, G;Földes, F;Kristóf, K;Barabás, E;Vásárhelyi, B;Prohászka, Z;Fodor, E;Jakab, F;Berki, T;Lacza, Z
    Q3
    PRACTICAL LABORATORY MEDICINE
    2021.
    DOI:10.1016/j.plabm.2021.e00222 (Copy DOI)
    19.
    Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura
    Pereira, LCV;Roose, E;Graça, NAG;Sinkovits, G;Kangro, K;Joly, BS;Tellier, E;Kaplanski, G;Falter, T;Von Auer, C;Rossmann, H;Feys, HB;Reti, M;Prohaszka, Z;Lämmle, B;Voorberg, J;Coppo, P;Veyradier, A;De Meyer, SF;Männik, A;Vanhoorelbeke, K
    D1
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS
    2021.
    DOI:10.1111/jth.15170 (Copy DOI)
    20.
    The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection
    Vásárhelyi, B;Kristóf, K;Ostorházi, E;Szabó, D;Prohászka, Z;Merkely, B
    Q4
    ORVOSI HETILAP
    2020.
    DOI:10.1556/650.2020.31859 (Copy DOI)
    21.
    Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children
    Sinkovits, G;Schnur, J;Hurler, L;Kiszel, P;Prohászka, ZZ;Sík, P;Kajdácsi, E;Cervenak, L;Maráczi, V;Dávid, M;Zsigmond, B;Rimanóczy, E;Bereczki, C;Willems, L;Toonen, EJM;Prohászka, Z
    D1
    SCIENTIFIC REPORTS
    2022.
    DOI:10.1038/s41598-022-23806-5 (Copy DOI)
    22.
    Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection
    Avraham, M;Sinkovits, G;Hurler, L;Prohászka, Z;Fishelson, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1337215 (Copy DOI)
    23.
    Complement C7 and clusterin form a complex in circulation
    Massri, M;Toonen, EJM;Sarg, B;Kremser, L;Grasse, M;Fleischer, V;Torres-Quesada, O;Hengst, L;Skjoedt, MO;Bayarri-Olmos, R;Rosbjerg, A;Garred, P;Orth-Höller, D;Prohászka, Z;Würzner, R
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1330095 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    24.
    Case Report: Early Onset Systemic Lupus Erythematosus Due to Hereditary C1q Deficiency Treated With Fresh Frozen Plasma
    Zecevic, M;Minic, A;Pasic, S;Perovic, V;Prohaszka, Z
    Q1
    FRONTIERS IN PEDIATRICS
    2021.
    DOI:10.3389/fped.2021.756387 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    25.
    Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children
    Stolbová, S;Bezdícka, M;Prohászka, Z;Csuka, D;Hrachovinová, I;Burkert, J;Simánková, N;Pruhová, S;Zieg, J
    Q1
    EUROPEAN JOURNAL OF PEDIATRICS
    2020.
    DOI:10.1007/s00431-020-03666-9 (Copy DOI)
    26.
    Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
    Delgado, IG;Corvillo, F;Nozal, P;Arjona, E;Madrid, A;Melgosa, M;Bravo, J;Szilágyi, A;Csuka, D;Veszeli, N;Prohászka, Z;Sánchez-Corral, P
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.641656 (Copy DOI)
    27.
    FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
    Garam, N;Cserhalmi, M;Prohászka, Z;Szilágyi, A;Veszeli, N;Szabó, E;Uzonyi, B;Iliás, A;Aigner, C;Schmidt, A;Gaggl, M;Sunder-Plassmann, G;Bajcsi, D;Brunner, J;Dumfarth, A;Cejka, D;Flaschberger, S;Flögelova, H;Haris, A;Hartmann, A;Heilos, A;Mueller, T;Rusai, K;Arbeiter, K;Hofer, J;Jakab, D;Sinkó, M;Szigeti, E;Bereczki, C;Janko, V;Kelen, K;Reusz, GS;Szabó, AJ;Klenk, N;Kóbor, K;Kojc, N;Knechtelsdorfer, M;Laganovic, M;Lungu, AC;Meglic, A;Rus, R;Levart, TK;Macioniene, E;Miglinas, M;Pawlowska, A...
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.720183 (Copy DOI)
    28.
    Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation
    Mezö, B;Horvath, O;Sinkovits, G;Veszeli, N;Krivan, G;Prohaszka, Z
    Q1
    FRONTIERS IN MEDICINE
    2020.
    DOI:10.3389/fmed.2020.569291 (Copy DOI)
    29.
    A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review
    Turudic, D;Milosevic, D;Bilic, K;Prohászka, Z;Bilic, E
    Q1
    JOURNAL OF CLINICAL MEDICINE
    2022.
    DOI:10.3390/jcm11102779 (Copy DOI)
    30.
    Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
    Kangro, K;Roose, E;Joly, BS;Sinkovits, G;Falter, T;von Auer, C;Rossmann, H;Reti, M;Voorberg, J;Prohászka, Z;Lämmle, B;Coppo, P;Veyradier, A;De Meyer, SF;Männik, A;Vanhoorelbeke, K
    D1
    BLOOD ADVANCES
    2021.
    DOI:10.1182/bloodadvances.2020004172 (Copy DOI)
    31.
    Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50
    Kovács, AL;Kárteszi, J;Prohászka, Z;Kalmár, T;Késmárky, G;Koltai, K;Nagy, Z;Sebok, J;Vas, T;Molnár, K;Berki, T;Böröcz, K;Gyömörei, C;Szalma, J;Egyed, M;Horváth, S;Oláh, P;Csuka, D;Németh, V;Gyulai, R
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.919411 (Copy DOI)
    32.
    Expanding Horizons in Complement Analysis and Quality Control
    Frazer-Abel, A.; Kirschfink, M.; Prohászka, Z.;
    Q1
    FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224
    2021.
    DOI:10.3389/fimmu.2021.697313 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    33.
    Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
    Uzonyi, B;Szabó, Z;Trojnár, E;Hyvärinen, S;Uray, K;Nielsen, HH;Erdei, A;Jokiranta, TS;Prohászka, Z;Illes, Z;Józsi, M
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.660382 (Copy DOI)
    34.
    Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia
    Ihnatko, M;Truchla, I;Ihnatkova, L;Prohaszka, Z;Lazurova, I
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2021.789972 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    35.
    Reducing the risk of infections in hereditary and acquired complement deficiencies Review of the literature and proposal for best practice in Hungary
    Eva, K;Beáta, O;Andrea, K;János, S;Vera, G;Gergely, K;Zoltán, P;Botond, L
    Q4
    ORVOSI HETILAP
    2023.
    DOI:10.1556/650.2023.32798 (Copy DOI)
    36.
    Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
    Haninger-Vacariu, N;Gleiss, A;Gaggl, M;Aigner, C;Kain, R;Prohászka, Z;Szilágyi, A;Csuka, D;Böhmig, GA;Sunder-Plassmann, R;Sunder-Plassmann, G;Schmidt, A
    Q1
    KIDNEY MEDICINE
    2023.
    DOI:10.1016/j.xkme.2023.100669 (Copy DOI)
    37.
    Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy
    Pusztai, A;Hamar, A;Horváth, A;Gulyás, K;Végh, E;Bodnár, N;Kerekes, G;Czókolyová, M;Szamosi, S;Bodoki, L;Hodosi, K;Domján, A;Nagy, G;Szöllosi, I;Lopez, LR;Matsuura, E;Prohászka, Z;Szántó, S;Nagy, Z;Shoenfeld, Y;Szekanecz, Z;Szucs, G
    Q1
    JOURNAL OF RHEUMATOLOGY
    2021.
    DOI:10.3899/jrheum.200916 (Copy DOI)
    38.
    Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
    Garam, N;Prohászka, Z;Szilágyi, A;Aigner, C;Schmidt, A;Gaggl, M;Sunder-Plassmann, G;Bajcsi, D;Brunner, J;Dumfarth, A;Cejka, D;Flaschberger, S;Flögelova, H;Haris, A;Hartmann, A;Heilos, A;Mueller, T;Rusai, K;Arbeiter, K;Hofer, J;Jakab, D;Sinkó, M;Szigeti, E;Bereczki, C;Janko, V;Kelen, K;Reusz, GS;Szabó, AJ;Klenk, N;Kóbor, K;Kojc, N;Knechtelsdorfer, M;Laganovic, M;Lungu, AC;Meglic, A;Rus, R;Kersnik-Levart, T;Macioniene, E;Miglinas, M;Pawlowska, A;Stompór, T;Podracka, L;Rudnicki, M;Mayer, G;R...
    Q1
    CLINICAL KIDNEY JOURNAL
    2020.
    DOI:10.1093/ckj/sfz073 (Copy DOI)
    39.
    Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus
    Larsen, ML;Troldborg, A;Toonen, EJM;Hurler, L;Prohaszka, Z;Cervenak, L;Hansen, AG;Thiel, S
    Q2
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    2023.
    DOI:10.1093/cei/uxad070 (Copy DOI)
    40.
    Complement multiplex testing: Concept, promises and pitfalls
    Prohászka, Z;Frazer-Abel, A
    Q2
    MOLECULAR IMMUNOLOGY
    2021.
    DOI:10.1016/j.molimm.2021.10.006 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    41.
    Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
    Aigner, C;Gaggl, M;Stemer, G;Eder, M;Bohmig, G;Kain, R;Prohaszka, Z;Garam, N;Csuka, D;Sunder-Plassmann, R;Piggott, LC;Haninger-Vacariu, N;Schmidt, A;Sunder-Plassmann, G
    Q1
    JOURNAL OF NEPHROLOGY
    2022.
    DOI:10.1007/s40620-021-00981-8 (Copy DOI)
    42.
    Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
    Aigner, C;Gaggl, M;Kain, R;Prohászka, Z;Garam, N;Csuka, D;Sunder-Plassmann, R;Piggott, LC;Haninger-Vacariu, N;Schmidt, A;Sunder-Plassmann, G
    JOURNAL OF CLINICAL MEDICINE
    2020.
    DOI:10.3390/jcm9040964 (Copy DOI)
    43.
    MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
    Petr, V;Csuka, D;Hruba, P;Szilágyi, A;Kollar, M;Slavcev, A;Prohászka, Z;Viklicky, O
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.985766 (Copy DOI)
    44.
    A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapy
    Karvaly, GB;Karádi, I;Vincze, I;Neely, MN;Trojnár, E;Prohászka, Z;Imreh, E;Vásárhelyi, B;Zsáry, A
    Q1
    PHARMACOLOGY RESEARCH & PERSPECTIVES
    2021.
    DOI:10.1002/prp2.856 (Copy DOI)
    45.
    Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
    Haninger-Vacariu, N;Aigner, C;Gaggl, M;Kain, R;Prohászka, Z;Böhmig, GA;Sunder-Plassmann, R;Sunder-Plassmann, G;Schmidt, A
    Q1
    CLINICAL KIDNEY JOURNAL
    2021.
    DOI:10.1093/ckj/sfaa113 (Copy DOI)
    46.
    Complement Genetics for the Practicing Allergist Immunologist: Focus on Complement Deficiencies
    Szilágyi, A;Csuka, D;Geier, CB;Prohászka, Z
    Q1
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
    2022.
    DOI:10.1016/j.jaip.2022.02.036 (Copy DOI)
    47.
    The Role of Mannose-binding Lectin in Infectious Complications of Pediatric Hemato-Oncologic Diseases
    Dobi, M;Szilágyi, A;Csuka, D;Varga, L;Prohászka, Z;Bereczki, C;Kovács, G;Fekete, F
    D1
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    2021.
    DOI:10.1097/INF.0000000000002919 (Copy DOI)
    48.
    Repeated spontaneous remission of atypical hemolytic-uremic syndrome caused by influenza – A case report
    Flögelová, H.; Volejníková, J.; Hrachovinová, I.; Prohászka, Z.; Šeda, M.; Gumulec, J.;
    Q4
    CESKO-SLOVENSKA PEDIATRIE / CZECHO-SLOVAK PEDIATRICS 0069-2328 1805-4501
    2020.
    49.
    Atypical HUS and Crohn's disease-interference of intestinal disease activity with complement-blocking treatment
    Horváth, O;Kelen, K;Prohászka, Z;Hosszú, A;Szabó, AJ;Reusz, GS
    Q1
    PEDIATRIC NEPHROLOGY
    2021.
    DOI:10.1007/s00467-021-05167-9 (Copy DOI)
    50.
    Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditis
    Szakal-Toth, Z;Szlavik, J;Soltesz, A;Berzsenyi, V;Csikos, G;Varga, T;Racz, K;Kiraly, A;Sax, B;Hartyanszky, I;Fintha, A;Prohaszka, Z;Monostory, K;Merkely, B;Nemeth, E
    Q2
    ESC HEART FAILURE
    2021.
    DOI:10.1002/ehf2.13271 (Copy DOI)
    51.
    Dense deposit disease in an adolescent male mimicking acute post-streptococcal glomerulonephritis
    Siomou, E;Liapis, G;Zisi, A;Csuka, D;Prohászka, Z
    Q4
    HIPPOKRATIA
    2020.
    52.
    A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome-Case Report
    Pollack, S;Eisenstein, I;Mory, A;Paperna, T;Ofir, A;Baris-Feldman, H;Weiss, K;Veszeli, N;Csuka, D;Shemer, R;Glaser, F;Prohaszka, Z;Magen, D
    Q1
    FRONTIERS IN IMMUNOLOGY
    2021.
    DOI:10.3389/fimmu.2021.608604 (Copy DOI)
    53.
    Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress
    Ariens, R;Becattini, C;Bender, M;Bergmeier, W;Castoldi, E;Devreese, K;Ellis, M;Gailani, D;Ignjatovic, V;James, PD;Kerrigan, S;Lambert, M;Lee, LH;Levi, M;Maugeri, N;Meijers, J;Melero-Martin, J;Michelson, AD;Mingozzi, F;Neeves, K;Ni, HY;Olsson, AK;Prohaszka, Z;Ranson, M;Riva, N;Senis, Y;van Ommen, CH;Vaughan, DE;Weisel, J
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
    2020.
    DOI:10.1002/rth2.12368 (Copy DOI)
    54.
    Exploring red cell distribution width as a biomarker for treatment efficacy in home mechanical ventilation
    Valko, L;Baglyas, S;Podmaniczky, E;Prohaszka, Z;Gal, J;Lorx, A
    Q2
    BMC PULMONARY MEDICINE
    2022.
    DOI:10.1186/s12890-022-01916-0 (Copy DOI)
    55.
    Serum fetuin-A level is independent of Helicobacter pylori postinfection status in systemic lupus erythematosus
    Márkus, B;Temesszentandrási, G;Vörös, K;Jakab, L;Fekete, B;Farkas, H;Prohászka, Z;Masszi, T;Kalabay, L
    Q3
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
    2022.
    DOI:10.1556/030.2022.01744 (Copy DOI)
    56.
    Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
    Ceglédi, A;Király, A;Várkonyi, A;Tasnády, S;Andrikovics, H;Fekete, M;Szabó, BG;Szemlaky, Z;Szilágyi, A;Sinkovits, G;Prohászka, Z;Réti, M;Mikala, G
    Q1
    PHARMACEUTICALS
    2024.
    DOI:10.3390/ph17121722 (Copy DOI)
    57.
    Anti-Inflammatory Cytokine Profiles in Thrombotic Thrombocytopenic Purpura-Differences Compared to COVID-19
    Demeter, F;Bihari, G;Vadicsku, D;Sinkovits, G;Kajdácsi, E;Horváth, L;Réti, M;Müller, V;Iványi, Z;Gál, J;Gopcsa, L;Reményi, P;Szathmáry, B;Lakatos, B;Szlávik, J;Bobek, I;Prohászka, ZZ;Förhécz, Z;Masszi, T;Vályi-Nagy, I;Prohászka, Z;Cervenak, L
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms251810007 (Copy DOI)
    58.
    Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
    Kelen, K;Horvath, O;Kis, E;Mikes, B;Sallay, P;Prohaszka, Z;Szabo, AJ;Reusz, GS
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms241814389 (Copy DOI)
    59.
    Dobrava hantavirus and coinciding SARS-CoV-2 infection mimicking thrombotic microangiopathy and responding to a single dose of eculizumab
    Aberger, S;Kozakowski, N;Proházka, Z;Pleininger, T;Salmhofer, H
    Q1
    CLINICAL KIDNEY JOURNAL
    2023.
    DOI:10.1093/ckj/sfad222 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    60.
    New-Onset Complement-Mediated Thrombotic Microangiopathy during the COVID-19 Pandemic
    Aigner, C;Gaggl, M;Schmidt, S;Kain, R;Kozakowski, N;Oszwald, A;Prohászka, Z;Sunder-Plassmann, R;Schmidt, A;Sunder-Plassmann, G
    Q2
    KIDNEY & BLOOD PRESSURE RESEARCH
    2024.
    DOI:10.1159/000541938 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    61.
    Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation
    Radnay, Z;Illés, A;Udvardy, M;Prohászka, Z;Sinkovits, G;Csányi, MC;Kellermayer, M;Kiss, A;Hársfalvi, J
    D1
    TRANSPLANTATION AND CELLULAR THERAPY
    2022.
    DOI:10.1016/j.jtct.2022.08.028 (Copy DOI)
    62.
    MAP-2:CD55 chimeric construct effectively modulates complement activation
    González-del-Barrio, L;Pérez-Alós, L;Cyranka, L;Rosbjerg, A;Nagy, S;Prohászka, Z;Garred, P;Bayarri-Olmos, R
    Q1
    FASEB JOURNAL
    2023.
    DOI:10.1096/fj.202300571R (Copy DOI)
    63.
    sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID
    Hurler, L;Mescia, F;Bergamaschi, L;Kajdácsi, E;Sinkovits, G;Cervenak, L;Prohászka, Z;Lyons, PA;Toonen, EJM
    D1
    ISCIENCE
    2024.
    DOI:10.1016/j.isci.2024.110162 (Copy DOI)
    64.
    Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology
    Simon, D;Kacsándi, D;Pusztai, A;Soós, B;Végh, E;Kerekes, G;Bodoki, M;Szamosi, S;Szucs, G;Prohászka, Z;Németh, P;Berki, T;Szekanecz, Z
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms25063429 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    65.
    External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years
    Kirschfink, M;Frazer-Abel, A;Balogh, E;Goseberg, S;Weiss, N;Prohászka, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1368399 (Copy DOI)
    66.
    High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
    Mezo, B;Reindl-Schwaighofer, R;Eskandary, F;Heinzel, A;Wahrmann, M;Doberer, K;Heilos, A;Bond, G;Kläger, J;Kozakowski, N;Haslacher, H;Oberbauer, R;Viklicky, O;Hrubá, P;Halloran, PF;Rusai, K;Prohászka, Z;Böhmig, GA
    Q2
    TRANSPLANTATION DIRECT
    2020.
    DOI:10.1097/TXD.0000000000000978 (Copy DOI)
    67.
    The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review
    Turudic, D;Pokrajac, D;Tasic, V;Kasumovic, D;Prohaszka, Z;Milosevic, D
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms241713041 (Copy DOI)
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    68.
    Acquired atypical haemolytic uremic syndrome - current perspectives of diagnosis and treatment: a clinical case report
    Hristova, M.; Kundurdzhiev, A.; Gancheva, R.; Ananiev, Y.; Prohaszka, Z.; Nikolova, M.;
    Q4
    Nephrology, Dialysis and Transplantation 1312-5257
    2024.
    Semmelweis University authors: Prohászka, Zoltán,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Belgyógyászati és Hematológiai Klinika,
    69.
    Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
    Haninger-Vacariu, N;Aigner, C;Kain, R;Prohászka, Z;Gaggl, M;Böhmig, GA;Piggott, LC;Sunder-Plassmann, R;Sunder-Plassmann, G;Schmidt, A
    Q3
    KIDNEY MEDICINE
    2020.
    DOI:10.1016/j.xkme.2019.12.004 (Copy DOI)
    70.
    Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients
    Aigner, C;Böhmig, GA;Eskandary, F;Herkner, H;Prohászka, Z;Csuka, D;Kain, R;Gaggl, M;Sunder-Plassmann, R;Müller-Sacherer, T;Oszwald, A;Fischer, G;Schmidt, A;Sunder-Plassmann, G
    Q2
    EUROPEAN JOURNAL OF INTERNAL MEDICINE
    2020.
    DOI:10.1016/j.ejim.2019.11.007 (Copy DOI)
    71.
    Az allogén vérképző őssejtátültetés korai szövődményei gyermekkorban
    Horváth, Orsolya; Nyirő, Judit; Kállay, Krisztián; Mező, Blanka; Kassa, Csaba; Hau, Lídia; Kertész, Gabriella; Horváth, Máté; Sinkó, János; Prohászka, Zoltán; Kriván, Gergely;
    HEMATOLÓGIA-TRANSZFUZIOLÓGIA 1786-5913
    2020.
    DOI:10.1556/2068.2020.53.3.4 (Copy DOI)
    72.
    "A gyermekkori depresszió rizikótényezői" kutatás - múlt, jelen, jövő
    Kapornai, K.; Baji, I.; Benák, I.; Dochnal, R.; Dósa, E.; Kiss, E.; Merkely, B.; Prohászka, Z.; Szabados, E.; Varga, A.; Vetró, Á.; Kovács, M.;
    Q4
    PSYCHIATRIA HUNGARICA 0237-7896
    2020.
    73.
    Pleuropneumonia, ami a háttérben állhat
    Kincs, Judit; Prohászka, Zoltán; Goda, Vera;
    GYERMEKORVOS TOVÁBBKÉPZÉS 1589-0309
    2021.

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library